Catalog

This series counts toward the new Drug Enforcement Administration (DEA) requirement for PAs treating and managing opioid use disorder (OUD) and substance use disorder (SUD). The series focuses on alcohol use disorder, pain management and opioids, dismantling the stigma, and more.

Even after the initial acute COVID-19 infection has subsided, patients are frequently left with short- or long-term sequelae post-infection. Many of these are similar to the sequelae of other severe pulmonary infections, sepsis, and/or intensive care unit admission. The organ systems affected are numerous and span the entire body. Particularly problematic are the cardiac, pulmonary, neurologic/cognitive, and thromboembolic sequelae. This educational program seeks to increase clinician awareness of these post-COVID-19 symptoms to emphasize the importance of treatment to avoid such outcomes. This is the final module of this series on the outpatient management of patients with COVID-19.

Even after the initial acute COVID-19 infection has subsided, patients are frequently left with short- or long-term sequelae post-infection. Many of these are similar to the sequelae of other severe pulmonary infections, sepsis, and/or intensive care unit admission. The organ systems affected are numerous and span the entire body. Particularly problematic are the cardiac, pulmonary, neurologic/cognitive, and thromboembolic sequelae. This educational program seeks to increase clinician awareness of these post-COVID-19 symptoms to emphasize the importance of treatment to avoid such outcomes. This is the final module of this series on the outpatient management of patients with COVID-19.

Earlier in the COVID-19 pandemic, treatment recommendations for COVID-19 were scattered with new data pouring in. As new treatments were tested, their efficacies were revealed and national guideline recommendations were made accordingly. Given the number of potential treatments, it is essential for clinicians to know the guidelines to treat their patients effectively and prevent poor outcomes. This is the second of three modules on the outpatient management of patients with COVID-19. The focus of this module is on treatment of mild-to-moderate COVID-19.

Earlier in the COVID-19 pandemic, treatment recommendations for COVID-19 were scattered with new data pouring in. As new treatments were tested, their efficacies were revealed and national guideline recommendations were made accordingly. Given the number of potential treatments, it is essential for clinicians to know the guidelines to treat their patients effectively and prevent poor outcomes. This is the second of three modules on the outpatient management of patients with COVID-19. The focus of this module is on treatment of mild-to-moderate COVID-19.

This activity will review the DSM-5 criteria for bipolar disorder types 1 and 2, as well as schizophrenia and subtypes. It also covers the nuance in these complex conditions and common presentations.

Research demonstrates patients with an alcohol use disorder (AUD) are twice as likely to be seen by their primary care provider than those without an AUD. Recent studies also find that healthcare providers may not be good at recognizing substance use disorders (SUDs) in the outpatient setting. Thus, there is a need for healthcare providers to recognize the sequelae of SUDs and better identify and assist alcohol or drug-dependent persons. This activity will provide an overview of screening, brief intervention, and referral to treatment for SUD and tools to incorporate alcohol and drug screening, intervention, and education into your daily practice and all aspects of medical care. We recognize that many healthcare workers already screen and assist. Still, we want to ensure that we are all asking the same questions and providing consistent, SBIRT-appropriate, evidence-based, and high-quality services.

The Roles of Neuroinflammation and Glutamatergic Excitotoxicity in Treatment-Resistant Depression | Recognizing and Managing Hydrocephalus in Children

Executive Leadership Conference (ELC) on Demand 2023 includes recorded content from the 2023 Executive Leadership Conference (ELC) that you can access online anytime. Executive Leadership Conference on Demand is designed to redefine how you approach leadership at your organization. The unique blend of sessions challenges you to refine your healthcare leadership competencies, lead through crisis, enhance your leadership skills, improve PA and NP revenue generation for your organization, and much more.

The use of telehealth has increased drastically during and since the COVID-19 pandemic, and telehealth has proven to be beneficial to both clinicians and patients. In rheumatology care in particular, telehealth is useful given the limited number of rheum